Related Experiment Videos
Liver transplantation for malignant tumors
B Koneru1, A Cassavilla, J Bowman
1Department of Surgery, University of Pittsburgh, Pennsylvania.
Gastroenterology Clinics of North America
|March 1, 1988
Summary
Liver transplantation for malignant tumors has poor outcomes. New adjunctive therapies are crucial for improving results in liver cancer patients undergoing this procedure.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Transplant Medicine
Background:
- Liver transplantation is a potential curative option for select patients with malignant liver tumors.
- Current outcomes for liver transplantation in patients with malignant tumors remain suboptimal.
- Significant advancements in surgical techniques and immunosuppression have improved graft and patient survival in liver transplantation.
Purpose of the Study:
- To review the current status and outcomes of liver transplantation for malignant tumors.
- To identify areas for improvement and future directions in the management of liver tumors via transplantation.
- To emphasize the need for novel adjunctive therapies to enhance treatment efficacy.
Main Methods:
- Comprehensive literature review of studies on liver transplantation for malignant tumors.
- Analysis of current clinical results and survival data.
- Discussion of existing and emerging adjunctive therapeutic modalities.
Main Results:
- Current results of liver transplantation for malignant tumors are suboptimal, with high rates of recurrence and mortality.
- Limited efficacy of existing treatments necessitates exploration of alternative strategies.
- Adjunctive therapies show promise but require further investigation and validation.
Conclusions:
- Liver transplantation for malignant tumors requires significant improvement in outcomes.
- Development and integration of novel adjunctive therapies are essential for progress.
- Future research should focus on multidisciplinary approaches to optimize patient selection and treatment protocols.